CeriXMedical Esthetics ApS
CVR number: 37349909
Købmagergade 24, 1150 København K
rie@cerix.dk
tel: 61616117
www.cerix.dk
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | 8 202.65 | 6 741.41 | 6 226.59 | 3 063.79 | 594.29 |
Employee benefit expenses | -6 024.25 | -4 784.18 | -3 374.22 | -3 984.99 | -4 959.18 |
Total depreciation | - 648.16 | - 641.20 | - 186.91 | - 161.54 | - 247.47 |
EBIT | 1 530.24 | 1 316.03 | 2 665.46 | -1 082.74 | -4 612.36 |
Other financial income | 264.66 | 497.64 | 270.42 | 366.56 | 321.73 |
Other financial expenses | -25.24 | -28.10 | -13.59 | -27.72 | - 395.52 |
Pre-tax profit | 1 769.66 | 1 785.57 | 2 922.29 | - 743.90 | -4 686.16 |
Income taxes | - 393.91 | - 397.92 | - 637.87 | 146.93 | 992.52 |
Net earnings | 1 375.76 | 1 387.65 | 2 284.42 | - 596.97 | -3 693.64 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Buildings | 31.60 | 18.27 | 8.59 | 2.83 | 18.69 |
Machinery and equipment | 957.34 | 758.19 | 1 240.89 | 1 085.12 | 842.54 |
Tangible assets total | 988.94 | 776.46 | 1 249.48 | 1 087.94 | 861.22 |
Other receivables | 98.08 | 2.94 | 2.94 | 2.94 | |
Investments total | 98.08 | 2.94 | 2.94 | 2.94 | |
Long term receivables total | |||||
Raw materials and consumables | 576.29 | 391.03 | 556.28 | 803.26 | 541.23 |
Inventories total | 576.29 | 391.03 | 556.28 | 803.26 | 541.23 |
Current trade debtors | 15.89 | 183.65 | 195.81 | 22.43 | 41.25 |
Current amounts owed by group member comp. | 8 392.96 | 3 801.20 | 6 580.55 | 5 860.08 | 3 855.43 |
Prepayments and accrued income | 0.82 | 126.85 | 60.27 | 68.92 | 12.45 |
Current other receivables | 1 439.73 | 1 689.60 | 1 986.11 | 2 029.68 | 3 486.72 |
Current deferred tax assets | 80.20 | 519.08 | |||
Short term receivables total | 9 929.59 | 5 801.31 | 8 822.73 | 7 981.11 | 7 914.93 |
Cash and bank deposits | 169.41 | 1 782.31 | 122.15 | 432.51 | 707.13 |
Cash and cash equivalents | 169.41 | 1 782.31 | 122.15 | 432.51 | 707.13 |
Balance sheet total (assets) | 11 762.31 | 8 754.05 | 10 753.58 | 10 307.76 | 10 024.51 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
Retained earnings | 1 116.04 | 2 491.80 | 3 879.45 | 6 002.15 | 5 405.18 |
Profit of the financial year | 1 375.76 | 1 387.65 | 2 284.42 | - 596.97 | -3 693.64 |
Shareholders equity total | 2 541.80 | 3 929.45 | 6 213.86 | 5 455.18 | 1 761.54 |
Provisions | 241.54 | 399.91 | 189.69 | ||
Non-current other liabilities | 257.17 | 237.72 | 418.88 | ||
Non-current deferred tax liabilities | 247.32 | 259.22 | |||
Non-current liabilities total | 257.17 | 237.72 | 418.88 | 247.32 | 259.22 |
Current loans from credit institutions | 82.12 | 106.63 | 73.66 | ||
Advances received | 17.50 | 37.00 | 65.21 | 109.91 | |
Current trade creditors | 1 178.62 | 421.63 | 200.20 | 623.18 | 617.98 |
Current owed to group member | 3 400.95 | 675.89 | 5 071.20 | ||
Short-term deferred tax liabilities | 436.15 | 76.19 | 479.50 | ||
Other non-interest bearing current liabilities | 3 865.51 | 3 830.03 | 2 897.60 | 2 977.62 | 2 204.65 |
Current liabilities total | 8 963.34 | 4 345.35 | 3 720.93 | 4 415.56 | 8 003.75 |
Balance sheet total (liabilities) | 11 762.31 | 8 754.05 | 10 753.58 | 10 307.76 | 10 024.51 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.